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Objective: To evaluate the staining characteristics of bromphe-
nol blue used during vitreoretinal surgery in humans.
Patients and methods: 13 patients with epiretinal membranes
were included. Before and after surgery a complete clinical
examination including best corrected visual acuity, funduscopy,
fluorescein angiography, OCT (Stratus), Goldmann perimetry
and multifocal ERG as well as photography of the macular area
was performed. Bromphenol blue was used in concentrations of
0.2% in most patients. Removed epiretinal tissue was evaluated
using electron microscopy.
Results: Using dye concentrations of 0.2% a good demarcation
of epiretinal membranes was seen in 11/13 patients. Staining
of vitreous remnants at the vitreous base was seen in all
patients. No dye-related adverse events were seen during
follow-up in the functional tests (VA, ERG, perimetry)
performed. Histological evaluation of epiretinal membranes
showed unremarkable aspects of epiretinal cellular layers and
unremarkable retinal surface of the internal limiting membrane
(ILM).
Conclusion: Bromphenol blue appears to be a very helpful and
safe tool in posterior segment surgery. The staining character-
istics need to be further evaluated in prospective study settings
and larger numbers of patients.
V
ital dyes potentially facilitate vitreoretinal surgery by
visualising nearly transparent structures such as the
internal limiting membrane (ILM) and epiretinal mem-
branes (ERM). Especially for surgeons at the beginning of their
learning curve the use of dyes may help to reduce the risk of
mechanical trauma and damage of underlying structures, such
as the nerve fibre layer, and allow for a more complete removal
of the target structure. Two dyes are currently available for
intraocular application: indocyanine green (ICG)1 and trypan
blue.2 Whereas ICG has been shown to selectively stain the
ILM,3 trypan blue is mainly used to visualise ERM.
ICG became the subject of ongoing discussion4–8 as clinical
and experimental data suggested dye-related toxicity, leading
to less favourable functional outcome after macular surgery. As
the underlying mechanisms of action as well as the safety
margins of ICG are not completely understood so far the
applicability of ICG seems to be limited. Although no
significant clinical adverse events have been reported for trypan
blue in humans, chronic and acute toxic effects have been seen
in animals and cell culture models.9 10
Therefore there appears to be a need for alternative dyes,
providing both satisfying staining characteristics and a good
safety profile. We initiated an investigation on novel dyes to
assess both potential toxic effects and staining characteristics in
different cell culture and animal models.11–13 As a result of these
studies, bromphenol blue appeared to be a promising candidate
for the application in humans.
In the present report, we describe the first experiences with
this novel dye obtained during vitreoretinal surgery for tractive
maculopathies such as macular holes and macular pucker.
METHODS
The study was approved by the local ethics committee and
institutional review board, and written informed consent was
obtained from all patients. Thirteen patients with macular
pucker, seven males and six females with a mean age of 65,
were included in the present study.
Preoperatively and postoperatively, patients underwent a
complete clinical examination including measurement of best
corrected visual acuity (VA), slit-lamp examination, tonometry,
Abbreviations: ERM, epiretinal membranes; ICG, indocyanine green; ILM,
internal limiting membrane; VA, visual acuity
Table 1 Complete data of the histological findings in the
membranes peeled off during surgery
Features of tissue fragments No. of cases (n = 8)
Inner limiting membrane
Present 7
Not present 1
Native vitreous collagen
None 4
Some 1
Continuous layer 3
Newly formed collagen
None 2
Some 2
Irregular masses 4
Fibrous long spacing collagen
Present 2
Not present 6
Cellular distribution
None 1
Single cells 0
Monolayer 1
Multilayer 6
Presence of
Fibrous astrocytes 3
Fibroblasts 7
Myofibroblasts 7
RPE cells 1
Macrophages 0
Predominating cell type
None 1
Fibrous astrocytes 0
Fibroblasts 4
Myofibroblasts 3
RPE cells 0
Macrophages 0
Retinal fragments at the ILM
None 1
Small fragments 4
Larger fragments 3
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funduscopy using a 78 diopter lens (Volk Optical, Mentor, OH,
USA), fluorescein angiography, OCT (Stratus), Goldmann
perimetry, multifocal ERG and fundus photograph. Patients
were seen one day before surgery and then in six-week
intervals. Postoperatively, ERG and Goldmann perimetry were
performed at the six-week follow-up visit and were not
repeated if unremarkable. All examinations were performed
by one of the authors (RS).
Bromphenol blue was dissolved and diluted using BSS plus
and sterilised using a 0.22 mm syringe filter and dye concentra-
tions of 0.02% and 0.2% were then injected into the eye.
Vitrectomy consisted of a standard three-port pars plana
vitrectomy as described in previous reports.4 5 Before injection
of the dye, a fluid air-exchange was performed to avoid an
uncontrolled dye distribution. Then, a few drops of the dye
were applied over the macular area. After a period of one
minute, the dye was completely washed out by irrigation. The
staining characteristics were then evaluated by the surgeon and
an additional examiner (CH). This was followed by removal of
epiretinal tissue and the ILM using an end-gripping forceps.
After the removal of epiretinal tissue, no second dye injection
was performed in this series of patients. Surgical procedures
were performed by one of the authors (AK).
All epiretinal tissue removed during surgery was harvested
and immediately prepared for ultrastructural analysis as
reported previously.4 Ultrathin sections were obtained from all
specimens, contrasted with uranyl acetate and lead citrate, and
analysed using a Zeiss EM 9 electron microscope (Zeiss Jena,
Germany). Histological evaluation of specimens was performed
by one of the coauthors who did not observe the surgical
procedure and had no access to other patient data (RGS).
RESULTS
We included 12 patients with idiopathic macular pucker and one
patient with ERM formation in association with proliferative
diabetic retinopathy. As no staining of epiretinal tissue was seen
during surgery using a dye concentration of 0.02% in the first
patient, all remaining patients were operated on using concentra-
tions of 0.2%. In patients with clinically visible ERM satisfying
staining of the membrane was seen in 11 of 13 cases (fig 1). In two
cases the staining effect was rather weak. We had the impression
that the staining effect varied depending on the thickness of the
ERM. Less staining was noted in cases where it appeared difficult
to remove an ERM, suggesting that the pathological alterations
were more pronounced within the retina and not on the retinal
surface. We did not observe sufficient staining of the ILM in our
patients with ERM. Staining of remnant vitreous in the periphery
at the vitreous base could be seen in all cases.
Overall patients’ VA increased from 0.16 preoperatively to
0.32 postoperatively. No loss of VA was seen. No dye-related
complications were observed in any functional test performed.
We found no affection of the amplitudes in postoperative ERG
examinations nor did we observe peripheral visual field defects
attributable to the dye. In one patient a visual field defect
occurred as a result of intraoperative damage to the retina with
the end-gripping forceps following a head movement of the
patient during peeling and one case of peripheral retinal
detachment was seen which was treated successfully by a
second vitrectomy with gas tamponade. In the patient with
proliferative diabetic retinopathy the visual field was affected
following panretinal photocoagulation before surgery. On
follow-up of 3 months, a decrease of mean retinal thickness
measured by OCT from 465.8 mm to 361.75 mm was seen.
Figure 1 Peeling of an epiretinal
membrane after staining with bromphenol
blue.
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Epiretinal membranes of 8 patients following vitrectomy
were evaluated using microscopy. The histological evaluation
focused on the appearance of the epiretinal cellular layers and
the amount of cellular debris on the retinal surface of the ILM
(fig 2). Epiretinal cells all had maintained their cellular
integrity. Small cellular fragments at the retinal surface of the
ILM were frequently noted (table 1).
DISCUSSION
With respect to reports on adverse effects following the use of
ICG,4–6 which is mainly used to stain the ILM, but also for
trypan blue,9 10 it seems reasonable to look for potential new
dyes with a better safety profile and reliable safety margins for
intraocular application. Several dyes are currently under
investigation experimentally11–15 and in humans.16
One dye, bromphenol blue, revealed promising staining
characteristics and an excellent safety profile11 12 and was
therefore further evaluated in humans in the present pre-
liminary case series. We observed that the staining effects of
bromphenol blue varied with less staining noted in cases where
hardly any tissue could be peeled off. Otherwise, a nice
demarcation of the membrane was observed. As a consequence,
we hypothesise that bromphenol blue might serve as a
diagnostic tool intraoperatively, helping to avoid excessive
peeling in cases of predominant intraretinal abnormalities.
We also observed a strong staining of vitreous remnants at
the vitreous base in all cases. This seems to be relevant as a
complete removal of the vitreous is crucial for surgical success
in many conditions. Vitreous staining might be a very helpful
tool, especially for less experienced surgeons, during surgery for
retinal detachment, where a thorough removal of vitreous in
the area of the retinal break is important, or tractive
retinopathy in proliferative diabetic retinopathy. In addition,
the detection and complete dye-assisted removal of vitreous
remnants on the retinal surface may provide enough relief of
tractional forces, for example in smaller (stage II) macular
holes, and ILM peeling might therefore not always be
necessary.
Histological evaluations of ERM removed during surgery
showed morphological features which were in line with
previous reports in the literature.17 Of note, we did not observe
a disruption of epiretinal cells or great amounts of cellular
debris on the retinal surface of the ILM as a sign of dye-related
toxicity as reported previously.5
A limitation of the present investigation is the rather small
number of patients and the lack of control groups including
other dyes or conventional surgery without staining. The
staining properties should therefore be further evaluated in
prospective studies incorporating larger numbers of patients. In
addition, higher dye concentrations might help to enhance the
staining properties. Nevertheless, one might argue that another
dye (trypan blue) is already available for ERM staining.
However, although adverse effects of trypan blue have not
been reported following clinical use in humans, several reports
have indicated chronic toxic effects of trypan blue in experi-
mental settings in vivo and ex vivo.9 10 18–20 Therefore, investiga-
tions into alternative dyes seem justified and necessary.
In summary, bromphenol blue provided good staining
properties in epiretinal membranes and vitreous and showed
a very good safety profile intraoperatively and during follow-up.
Statements on long-term safety can not be made before a
longer period of review. In addition, further studies are required
Figure 2 Transmission electron
micrographs of the internal limiting
membrane (ILM) and epiretinal tissue
removed by bromphenol blue-assisted
peeling. The ILM was present in most
specimens, with native vitreous collagen
being interspersed between the ILM and
epiretinal cells in many specimens. Newly
formed collagen was also seen irregularly
distributed between the ILM and cellular
elements as well as embedded in areas with
cellular proliferation. We observed fibrous
astrocytes, fibroblasts, myofibroblasts and
RPE cells.Top left, en-bloc peeling of an
irregular layer of cells (arrow) and collagen
(arrowhead) directly attached to the vitreal
side of the ILM (asterisk) (original
magnification, x1000; bar = 10.1 mm).Top
right, the ILM devoid of cells and collagen
(original magnification x3600, bar
= 2.8 mm).Bottom left, densely packed cells
with numerous microvillous processes
(arrows) on a layer of native vitreous
collagen in areas without contact to the ILM
(original magnification, x3600; bar
= 2.8 mm).Bottom right, fibroblast (arrow)
with cellular nucleus and abundant
endoplasmatic reticulum at the ILM (asterisk),
newly formed collagen (arrowhead) sparsely
distributed between fibroblast and ILM
(original magnification, x9500; bar
= 1.0 mm).
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to compare the functional outcome of bromphenol blue-
assisted vitrectomy to other dyes such as trypan blue or
conventional surgery without staining.
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